Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-11 Sale | 2026-09-15 8:27 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 75,364 | $3.403 | $256,464 | 598,489 (Direct) | View |
| 2026-08-18 Sale | 2026-08-20 5:30 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 631 | $3.381 | $2,133 | 673,853 (Direct) | View |
| 2026-08-18 Sale | 2026-08-20 5:25 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 2,293 | $3.381 | $7,753 | 1,462,832 (Indirect Direct) | View |
| 2026-08-13 Sale | 2026-08-17 5:52 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 2,837 | $3.381 | $9,592 | 1,465,125 (Indirect Direct) | View |
| 2026-08-13 Sale | 2026-08-17 5:50 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 3,493 | $3.381 | $11,810 | 674,484 (Direct) | View |
| 2026-08-11 Sale | 2026-08-13 4:15 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Stevens Christopher James Chief Operating Officer | 36,658 | $3.499 | $128,266 | 505,784 (Direct) | View |
| 2026-08-11 Sale | 2026-08-13 4:15 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Chaudhuri Sarbani See Remarks | 4,701 | $3.499 | $16,449 | 262,809 (Direct) | View |
| 2026-05-21 Sale | 2026-05-26 7:47 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 55,684 | $3.086 | $171,841 | 1,467,962 (Indirect Direct) | View |
| 2026-05-19 Sale | 2026-05-21 4:06 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 2,409 | $3.014 | $7,261 | 1,447,156 (Indirect Direct) | View |
| 2026-05-19 Sale | 2026-05-21 4:06 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 662 | $3.014 | $1,995 | 677,977 (Direct) | View |
| 2026-05-19 Sale | 2026-05-21 4:06 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 384 | $3.014 | $1,157 | 89,780 (Direct) | View |
| 2026-05-13 Sale | 2026-05-14 4:22 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 3,361 | $3.606 | $12,120 | 678,639 (Direct) | View |
| 2026-05-13 Sale | 2026-05-14 4:19 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 2,728 | $3.606 | $9,837 | 1,449,565 (Indirect Direct) | View |
| 2026-05-13 Sale | 2026-05-14 4:16 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 855 | $3.606 | $3,083 | 90,164 (Direct) | View |
| 2026-05-07 Sale | 2026-05-11 7:48 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Chaudhuri Sarbani See Remarks | 17,650 | $3.838 | $67,741 | 267,510 (Direct) | View |
| 2026-02-18 Sale | 2026-02-20 4:31 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 1,157 | $3.338 | $3,862 | 91,019 (Direct) | View |
| 2026-02-18 Sale | 2026-02-20 4:26 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 5,990 | $3.338 | $19,995 | 1,452,293 (Indirect Direct) | View |
| 2026-02-18 Sale | 2026-02-20 4:09 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 1,376 | $3.338 | $4,593 | 682,000 (Direct) | View |
| 2026-02-13 Sale | 2026-02-18 5:42 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 12,253 | $3.312 | $40,582 | 683,376 (Direct) | View |
| 2026-02-13 Sale | 2026-02-18 5:38 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 3,726 | $3.312 | $12,341 | 92,176 (Direct) | View |
| 2026-02-13 Sale | 2026-02-18 5:33 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 12,279 | $3.312 | $40,668 | 1,458,283 (Indirect Direct) | View |
| 2026-01-02 Purchase | 2026-01-06 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 10,000 | $3.44 | $34,400 | 50,000 (Direct) | View |
| 2025-11-18 Sale | 2025-11-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 2,545 | $2.983 | $7,592 | 299,064 (Direct) | View |
| 2025-11-18 Sale | 2025-11-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 1,086 | $2.983 | $3,240 | 65,920 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-03 Option Award | 2026-08-05 8:49 pm | N/A 2036-08-03 | ROCKET PHARMACEUTICALS INC. | RCKT | Stevens Christopher James Chief Operating Officer | 174,741 | $0 | 643,870 (Direct) | View |
| 2026-08-03 Other | 2026-08-05 8:45 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director | 150,000 | $0 | 467,646 (Direct) | View |
Ownership | 2026-07-08 7:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Manhede Joseph Principal Accounting Officer | 0 | $0 | 52,576 (Direct) | View |
| 2026-06-18 Option Award | 2026-07-06 8:00 pm | N/A 2036-06-18 | ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner | 106,792 | $0 | 18,342,916 (Direct) | View |
| 2026-06-18 Option Award | 2026-07-06 8:00 pm | N/A 2036-06-18 | ROCKET PHARMACEUTICALS INC. | RCKT | Fong Peter Director | 87,722 | $0 | 141,055 (Direct) | View |
| 2026-06-18 Option Award | 2026-07-06 7:59 pm | N/A 2036-06-18 | ROCKET PHARMACEUTICALS INC. | RCKT | Dolsten Mikael Director | 87,722 | $0 | 131,942 (Direct) | View |
| 2026-06-18 Option Award | 2026-07-06 7:59 pm | N/A 2036-06-18 | ROCKET PHARMACEUTICALS INC. | RCKT | Malik Fady Ibraham Director | 87,722 | $0 | 117,722 (Direct) | View |
| 2026-06-18 Option Award | 2026-07-06 7:59 pm | N/A 2036-06-18 | ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director | 87,722 | $0 | 232,506 (Direct) | View |
| 2026-06-18 Option Award | 2026-07-06 7:59 pm | N/A 2036-06-18 | ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director | 87,722 | $0 | 117,722 (Direct) | View |
| 2026-05-26 Option Award | 2026-05-28 4:33 pm | N/A 2031-05-26 | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 116,562 | $0 | 116,562 (Direct) | View |
| 2026-05-21 Exercise | 2026-05-26 7:47 pm | N/A 2027-04-12 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 76,490 | $1.691 | 1,467,962 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 4:05 pm | N/A 2036-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 1,156,676 | $0 | 2,341,210 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 4:05 pm | N/A 2036-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 75,000 | $0 | 140,920 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 4:05 pm | N/A 2036-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 780,000 | $0 | 1,163,816 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 4:05 pm | N/A 2036-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Rizvi Syed Ali-aamir Chief Medical Officer | 155,000 | $0 | 500,911 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 4:05 pm | N/A 2036-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Stevens Christopher James Chief Operating Officer | 155,000 | $0 | 562,166 (Direct) | View |
| 2026-02-11 Option Award | 2026-02-13 4:05 pm | N/A 2036-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Chaudhuri Sarbani See Remarks | 315,000 | $0 | 474,236 (Direct) | View |